Modern pharmaceutical companies are undergoing a significant transformation with opportunities presented by digitization, big data, and analytics. Post COVID19, businesses are seeing an increased need for an agile enterprise Business Intelligence (BI) architecture to leverage these opportunities & seamlessly deliver business-critical insights to executives. Successful Pharmaceutical companies go beyond standard operational & statutory reports and are implementing more powerful Analytics and AI-driven solutions. These solutions provide actionable insights and useful performance indicators for efficient decision making. The more actionable your reporting is, the more empowered your team gets to enable the right engagement that ultimately drives results for your organization.